The Research Group on Integrative Biomedical Materials and Nanomedicine Lab is led by Dr. Pilar Rivera. The group converts basic research findings on nanobiotechnology into new approaches addressing biomedical challenges. They fabricate multifunctional biomaterials by integrating selected building-blocks into one single system depending on the application's requirements and considering the biophysicochemical properties of the nanomaterial. They group targets independently two areas: diagnostics and therapeutics of diseases but also simultaneously by creating a theranostic tool towards a more personalized medicinal approach of diseases. They focus on understanding and engineering the nanomaterial-biological system interface. They use state of the art material and biological/molecular characterization methods to find predictive patterns of cellular outcomes after exposure to nanomaterials for translational medicine.